ConductScience.org, home

Paper4875305

The biology of graft-versus-host reactions.

Billingham RE. Harvey Lect, 1966. Cited by 342 papers, by iCite.

Cite this record

ConductScience Library. The biology of graft-versus-host reactions. Papers, record 4875305. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4875305

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The biology of graft-versus-host reactions.
PubMed
Journal
Harvey Lect
PubMed
Year
1966
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
342
iCite
Revised in PubMed
2006-07-19
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Billingham RER E

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graft vs Host DiseaseMajor topic
Infant, Newborn, DiseasesMajor topic
Transplantation ImmunologyMajor topic
Age Factors
Animals
Chickens
Humans
Immune Sera
Immunity
Infant, Newborn
Lymphoid Tissue
Mammals
Mice
Parabiosis
Radiation Effects
Rats
Salmonella Infections
Salmonella typhimurium
Splenomegaly
Thymectomy
Transplantation, Homologous
Vaccines
Virus Diseases

Source PubMed

Download CSV of topics

Cited by140

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 342 citations.

PMIDTitleJournalYearIn PapersSource
41655162Designing immune reconstitution to prevent graft-versus-host disease: a novel therapeutic paradigm beyond T cell suppression.Int J Hematol2026https://conductscience.org/library/papers/41655162PubMed
40117296Cellular therapies for the prevention and treatment of acute graft-versus-host disease.Stem Cells2025https://conductscience.org/library/papers/40117296PubMed
39916964Case report: Toxic epidermal necrolysis as a unique presentation of acute graft versus host disease in a pediatric patient.Front Immunol2024https://conductscience.org/library/papers/39916964PubMed
39328417Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Front Immunol2024https://conductscience.org/library/papers/39328417PubMed
39233318Population pharmacokinetic modeling of vedolizumab for graft-versus-host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant.Pharmacol Res Perspect2024https://conductscience.org/library/papers/39233318PubMed
39035005A strategy to reconstitute immunity without GVHD via adoptive allogeneic Tscm therapy.Front Immunol2024https://conductscience.org/library/papers/39035005PubMed
38558826Research advances on short-chain fatty acids in gastrointestinal acute graft-versus-host disease.Ther Adv Hematol2024https://conductscience.org/library/papers/38558826PubMed
37761936The Role of MicroRNA in Graft-Versus-Host-Disease: A Review.Genes (Basel)2023https://conductscience.org/library/papers/37761936PubMed
37291149Acute graft-versus-host disease.Nat Rev Dis Primers2023https://conductscience.org/library/papers/37291149PubMed
37247105Acute Graft-versus-Host Disease: An Update on New Treatment Options.Drugs2023https://conductscience.org/library/papers/37247105PubMed
36544776Milestones in acute GVHD pathophysiology.Front Immunol2022https://conductscience.org/library/papers/36544776PubMed
36187719Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation.World J Biol Chem2022https://conductscience.org/library/papers/36187719PubMed
36166494Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36166494PubMed
36039647C-C chemokine receptor 5 and acute graft-versus-host disease.Immun Inflamm Dis2022https://conductscience.org/library/papers/36039647PubMed
35814515Acute Graft Versus Host Disease Following Liver Transplantation: Case Report With Review of Current Literature.J Clin Exp Hepatol2022https://conductscience.org/library/papers/35814515PubMed
35782373Graft versus host disease after liver transplantation: A case report.Hepatol Forum2022https://conductscience.org/library/papers/35782373PubMed
35679154Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/35679154PubMed
35657433STR typing of skin swabs from individuals after an allogeneic hematopoietic stem cell transplantation.Int J Legal Med2023https://conductscience.org/library/papers/35657433PubMed
35386853Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?Drug Des Devel Ther2022https://conductscience.org/library/papers/35386853PubMed
34786412Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: Report of six cases.World J Clin Cases2021https://conductscience.org/library/papers/34786412PubMed

See all 140 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4875305

GET https://conductscience.org/api/papers/v1/4875305/cited_by?page=2